Anne Bergeron, MD, PhD is an expert in Pulmonology at University Hospital of Geneva (Switzerland). As of October 2026, ScienceLeadR ranks Anne Bergeron in the top 1% of experts worldwide for Bronchiolitis, Bronchitis and Pneumonia. Anne Bergeron has authored 311 publications, the most recent in 2026, and is an investigator in 21 clinical trials, 1 of them ongoing. SLR score: 1,113 (community average: 125). How the SLR is computed.

LeadR Profile

Anne Bergeron, MD, PhD University Hospital of Geneva Switzerland
1 113 ScienceLeadR Reputation 1113
Network Map

Pulmonology

Subspecialties: Transplantation - Infectiology - Critical Care

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2002 - 2026

Source: PubMed

Université Paris Cité

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 311

Citations

Citations: 12 650 1st author: 33 Last author: 50 Unique author: 4


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
The Lung Function Score Retains Prognostic Value Under Z-Score-Based Interpretation.
PMID 42720616 — lung, respiratory tract diseases
Ann Am Thorac Soc20260
Reply to Couderc et al.: Non-invasive management of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
PMID 42142354 — cells, microscopy, electron, scanning transmission, hematopoietic stem cell transplantation, critical care, stem cells, bronchiolitis obliterans, cell transplantation, stem cell transplantation, hematopoietic stem cells, transplantation, bronchiolitis, bronchiolitis obliterans syndrome
Am J Respir Crit Care Med20260
A statistical Model for Lung Function Trajectory and Mortality in Patients with Fibrotic Interstitial Lung Disease.
PMID 42085272 — bias, mortality, lung, critical care, therapeutics, lung diseases, vital capacity, models, statistical, lung diseases, interstitial
Am J Respir Crit Care Med20260
Economic burden of pulmonary arterial hypertension in Switzerland.
PMID 42048354 — hypertension, financial stress, pulmonary arterial hypertension, work, therapeutics
PLoS One20260
Bronchiectasis in patients with bronchiolitis obliterans syndrome: toward phenotyping BOS?
PMID 41888296 — bone marrow transplantation, bronchiolitis obliterans, bronchiectasis, bronchiolitis, bronchiolitis obliterans syndrome
Bone Marrow Transplant20260

Clinical Studies 21

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 5

By phase:

Phase 2 11
N/A 6
Phase 3 2
Phase 2/Phase 3 1
Phase 4 1

By status:

Completed 16
Unknown 3
Recruiting 2

By type:

Interventional 19
Observational 2

By Monocentric/Multicentric:

monocentric 8
multicentric2to4 2
multicentric5to9 1
multicentricup10 10

Main Topics

Cohort/Consortium Investigators 3

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Breathlessness Patterns in Patients With Cancer COPD and Heart Failure an fMRI Feasibility Study
NCT07319039 — virtual reality, feasibility studies, chronic disease, neuroimaging, heart failure, echo-planar imaging, heart, brain, neoplasms, palliative medicine, multiple chronic conditions, solutions, pulmonary disease, chronic obstructive, therapeutics, lung diseases, dyspnea, environment, lung diseases, obstructive, voice, medical devices
N/ARecruiting2025

LeadR Networks

Main global connection map